Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry

The new Hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early ...

 May 05, 2022 | News

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

 CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered...

 May 04, 2022 | News

Inmagene Receives FDA's IND Clearance for OX40 Antagonist

IMG-007 is highly potent at blocking the binding of OX40 to OX40L, thereby reducing OX40L-dependent downstream signaling and cytokine release by T cells. I...

 May 03, 2022 | News

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the FDA for an EV...

 April 28, 2022 | News

PharmAbcine Announces Positive Results for Its Novel TIE2-Activating Antibody in GLP Toxicology Study

PMC-403 can stabilize and repair damaged and pathologically leaky blood vessels, and it is being developed to treat AMD (Age-related Macular Degeneration),...

 April 27, 2022 | News

Biopharmaceuticals: Faster to Market

To combat these challenges, biopharmaceuticals that are produced with the help of living organisms are playing an increasingly important role. However, the...

 April 21, 2022 | Opinion

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn

Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia ...

 April 14, 2022 | News

Cambrex Completes Large-Scale US API Expansion

The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex's fl...

 April 13, 2022 | News

Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative

Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by inves...

 April 12, 2022 | News

CR Pharma intends to make strategic equity investment for Everest's mRNA technology platform

Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancemen...

 April 07, 2022 | News

Singlera Genomics announces research collaboration with Astellas Pharma

Singlera Genomics Inc. today announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to better understand biologica...

 April 06, 2022 | News

CBC Group continues to expand its global healthcare ecosystem to fulfil unmet medical needs

Hasten fast-tracks transformative medicines for patients in China Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has ...

 April 01, 2022 | News

Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06

The Phase I clinical trial, a randomized, double-blind and placebo-controlled study, is to evaluate the safety, pharmacokinetics and pharmacodynamics of si...

 April 01, 2022 | News

Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland

Due to the company’s technologies, its deep scientific knowhow and the specialized skills of the Paras Biopharma team, all of Paras Biopharmaceutical...

 March 29, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in